Patient Compliance: Voluntary cooperation of the patient in following a prescribed regimen.Compliance: Distensibility measure of a chamber such as the lungs (LUNG COMPLIANCE) or bladder. Compliance is expressed as a change in volume per unit change in pressure.Insurance, Hospitalization: Health insurance providing benefits to cover or partly cover hospital expenses.Drug Packaging: Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.Lung Compliance: The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562)Chemistry, Pharmaceutical: Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.Delayed-Action Preparations: Dosage forms of a drug that act over a period of time by controlled-release processes or technology.Administration, Oral: The giving of drugs, chemicals, or other substances by mouth.Transdermal Patch: A medicated adhesive patch placed on the skin to deliver a specific dose of medication into the bloodstream.Tablets: Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)Cathartics: Agents that are used to stimulate evacuation of the bowels.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Medication Adherence: Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.Drug Administration Schedule: Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.Drug Compounding: The preparation, mixing, and assembling of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814)Treatment Refusal: Patient or client refusal of or resistance to medical, psychological, or psychiatric treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.)Orthodontic Appliances: Devices used for influencing tooth position. Orthodontic appliances may be classified as fixed or removable, active or retaining, and intraoral or extraoral. (Boucher's Clinical Dental Terminology, 4th ed, p19)Occult Blood: Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.Tooth Movement: Orthodontic techniques used to correct the malposition of a single tooth.Drug Delivery Systems: Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.Patient Education as Topic: The teaching or training of patients concerning their own health needs.Capsules: Hard or soft soluble containers used for the oral administration of medicine.Orthodontic Appliance Design: The planning, calculation, and creation of an apparatus for the purpose of correcting the placement or straightening of teeth.Drug Therapy: The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.Drug Therapy, Combination: Therapy with two or more separate preparations given for a combined effect.Administration, Cutaneous: The application of suitable drug dosage forms to the skin for either local or systemic effects.Drug Carriers: Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.Self Administration: Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Technology, Pharmaceutical: The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.Patient Satisfaction: The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Practice Guidelines as Topic: Directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Biological Availability: The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.Administration, Topical: The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.Drug Combinations: Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.Cross-Over Studies: Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)Anti-Bacterial Agents: Substances that reduce the growth or reproduction of BACTERIA.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Physician-Patient Relations: The interactions between physician and patient.Colonoscopy: Endoscopic examination, therapy or surgery of the luminal surface of the colon.Antihypertensive Agents: Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.Guideline Adherence: Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Equipment Design: Methods of creating machines and devices.Hypoglycemic Agents: Substances which lower blood glucose levels.Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.Randomized Controlled Trials as Topic: Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.Helicobacter pylori: A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).Double-Blind Method: A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.Health Knowledge, Attitudes, Practice: Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL).Mass Screening: Organized periodic procedures performed on large groups of people for the purpose of detecting disease.United StatesSolubility: The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Recurrence: The return of a sign, symptom, or disease after a remission.Vascular Capacitance: The measure of a BLOOD VESSEL's ability to increase the volume of BLOOD it holds without a large increase in BLOOD PRESSURE. The vascular capacitance is equal to the change in volume divided by the change in pressure.Elasticity: Resistance and recovery from distortion of shape.Hand Hygiene: Practices involved in preventing the transmission of diseases by hand.Arteries: The vessels carrying blood away from the heart.
Bell later determined, however, that a significant percentage of patient files were not in compliance because they lacked the ... In the following two years, 79 information reports resulted in 68 regular investigations and 71 information reports resulted in ... When they arrived, Bell told them the results of her audit. They informed Bell that they knew that they were significantly out ... Traditional event monitoring requires the patient to press a button when he or she notices a cardiac event to record the ...
Expiratory flow is determined by patient factors such as compliance and resistance. Mechanical dead space is defined as the ... It was refined and used in the 20th century largely as a result of the polio epidemic that struck the world in the 1940s. The ... In such patients, some experts recommend limiting PEEP to low levels (~10cmH2O). In patients who have diffused loss of aeration ... One of the main reasons why a patient is admitted to an ICU is for delivery of mechanical ventilation. Monitoring a patient in ...
Over 90% of hospitalized patients receive some form of IV therapy during their stay. As a result, infusion devices must be safe ... They feature a unique passive technology that cannot accept a needle, ensuring compliance with needle-free policies. These ... Blood reflux can lead to an intraluminal thrombus, which may result in an inability to infuse IV fluids/medications, an ... ICU Medical's products are designed to assist clinicians in enhancing patient safety and improving outcomes by helping prevent ...
The results of trials are often included in the labelling of the medication to provide information both for patients and the ... They may also lead to non-compliance with a treatment regimen. Adverse effects of medical treatment resulted in 142,000 deaths ... In patients with end-stage cancer, death is a very likely outcome and whether the drug is the cause or a bystander is often ... If it results from an unsuitable or incorrect dosage or procedure, this is called a medical error and not a complication. ...
Often this route of treatment is difficult because it depends most heavily on patient compliance. Once pharmacological ... Laryngeal dystonia or spasmodic dysphonia results from abnormal contraction of muscles in the voice box, resulting in altered ... These sensations usually occur in the evening, while the patient is sitting or lying down and relaxing. Patients feel like they ... Wilson's disease (WD) is a rare inherited disorder in which patients have a problem metabolizing copper. In patients with WD, ...
Reduced patient compliance with the collection of three samples hampers the usefulness of this test. Further discussion of ... Gastrointestinal bleeding has many potential sources, and positive results usually result in further testing for the bleeding ... "Screening average risk patients for colorectal cancer - B01". Retrieved 2007-10-25. Harewood GC, McConnell JP, Harrington JJ, ... Kewenter J, Brevinge H, Engarås B, Haglind E, Ahrén C (May 1994). "Results of screening, rescreening, and follow-up in a ...
They may also lead to non-compliance with a treatment regimen. Adverse effects of medical treatment resulted in 142,000 deaths ... The results of trials are often included in the labelling of the medication to provide information both for patients and the ... " Retrieved March 20, 2013.. *^ "Metoclopramide & Tardive Dyskinesia". Tardive Dyskinesia Center. Archived from the ... In patients with end-stage cancer, death is a very likely outcome and whether the drug is the cause or a bystander is often ...
AdM coaches identify patients at high risk for readmission as a direct result of not following their discharge plan. Once ... In 2012, Grace Lomax completed a study in the United Kingdom regarding patient non-compliance/adherence/concordance/etc. "What ... Clinical improvement requires that the patient, significant others and their AdM coach know the results the provider is looking ... Millions of man hours, patient and provider, have been spent training and documenting the fact that the patient was made aware ...
Accordingly, attachment styles influence patient perception of illness, health care utilization, medication compliance and ... quality of life and renal function in adult patients after kidney transplant: preliminary results". Renal Failure. 37 (4): 678- ... Bennett, JK; Fuertes, JN; Keitel, M; Phillips, R (2011). "The role of patient attachment and working alliance on patient ... "The Influence of Adult Attachment on Patient Self-Management in Primary Care - The Need for a Personalized Approach and Patient ...
Poor compliance with medications and follow-up visits is a major reason for vision loss in glaucoma patients. A 2003 study of ... Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open- ... Neovascular glaucoma results when new, abnormal vessels begin developing in the angle of the eye that begin blocking the ... Long-term results are not available. The most common conventional surgery performed for glaucoma is the trabeculectomy. Here, a ...
Contusion can also permanently reduce the compliance of the lungs. Pulmonary contusion can result in respiratory failure-about ... CT scanning also helps determine the size of a contusion, which is useful in determining whether a patient needs mechanical ... Pulmonary lacerations may result from the same blunt or penetrating forces that cause contusion. Lacerations can result in ... As a result of damage to capillaries, blood and other fluids accumulate in the lung tissue. The excess fluid interferes with ...
Methods to improve compliance include subdermal implants, which release the drug continuously over a period of up to 12 weeks, ... About 5 to 10 minutes after alcohol intake, the patient may experience the effects of a severe hangover for a period of 30 ... the excess dopamine results in increased anxiety, elevated blood pressure, restlessness, and other unpleasant symptoms.[ ... The reason for this finding was that only 20% of subjects in disulfiram group were estimated to be in good compliance with the ...
... significant increases in patient compliance with recommended treatments and potential cost savings result. The concept of Value ... The program resulted in an increase in net payments for drugs used in the treatment of asthma, hypertension, and diabetes, but ... The result was large decreases in the use of diagnostic testing and outpatient procedures that were sustained for four years, ... The basic V-BID premise is to align patients' out-of-pocket costs, such as copayments and premiums, with the value of health ...
... or transfer to a base-priced drug would cause patient confusion resulting in problems with compliance. Such an exemption ... The patient must pay this TGP in addition to the normal patient co-payment contribution if they have been prescribed such a ... For a written Authority however, evidence of diagnosis and patient eligibility criteria such a pathology test results are ... The patient pays the Brand Premium in addition to the normal patient contribution if they decline to purchase the generic brand ...
Compliance, or lack thereof, in taking the drug at the times and dose prescribed. In the case of a surgically implanted device ... Traditional trials do not adapt the treatment to the covariates of subjects: Taking account of factors such as the patient's ... Such adjustments often bias the results of the study, and so many health authorities mandate that clinical trials analyse the ... Accurate computer models of a treatment and its deployment, as well as patient characteristics, are necessary precursors for ...
... to the 20 µg/mL concentration using the I-neb AAD System will decrease treatment times to help maintain patient compliance. The ... patients who are maintained at the 5 µg dose and who have repeatedly experienced extended treatment times which could result in ... The majority of patients (> 80%) in the pivotal study used this median dose or a higher dose with an excellent treatment ... Any patient who cannot tolerate the 5 µg dose should be maintained at 2.5 µg. Each inhalation treatment requires one entire ...
Tablets are generally taken enterally, as the size and stiffness of the form results in poor patient compliance when ... The net result is the formation of a double layer of charges that are attracted to each other due to balancing of the Fermi ... This results in unpredictable losses of the drug, as the non-solid dosage is unable to maintain its position at the site of ... As a liquid or semisolid dosage, gels are typically used where a solid form would affect the patient's comfort. As a trade-off ...
... a result supported by a meta-analysis by Leucht et al. published in The Lancet), although more patients discontinued ... Compliance has not been shown to be different between the two types. Overall evaluations of the CATIE and other studies have ... Patients with increased histamine levels have been observed to have lower serotonin levels. However, the H1 receptor is linked ... Adverse effects in patients with dementia include an increased risk of mortality and cerebrovascular events, as well as ...
The former employees said that these goals had resulted in an admission of more than 50% of patients aged 65 or over, ... Paul Meyers, HMA's former director of compliance and a 30-year FBI veteran, accused the chain of Medicare fraud. The hospital ... The Justice Department accused HMA of admitting patients to hospitals regardless of whether they needed hospital care and ... 42,000 individuals in clinical and support roles enables HMA the ability to provide 3.5 million patient interactions yearly ...
... and increased patient compliance. As patients may feel better before treatment is complete and discontinue treatment too early ... Since acquisition, brilacidin has to date completed a Phase 2b clinical trial with positive results. Results, as detailed below ... A single one day dosage eliminates the risk of patient non-compliance. Efficacy and Safety Study of Brilacidin to Treat Serious ... This is currently the most important bacterial pathogen in patients with ABSSSI. The P2b clinical trial results were reported ...
The therapeutic target range TSH level for patients on treatment ranges between 0.3 and 3.0 μIU/mL. For hypothyroid patients on ... Interpretation of the results depends on both the TSH and T4 concentrations. In some situations measurement of T3 may also be ... An increase in TSH above the normal range indicates under-replacement or poor compliance with therapy. A significant reduction ... For hyperthyroid patients, both TSH and T4 are usually monitored. It must also be noted that in pregnancy, TSH measurements do ...
An important aspect of the revenue cycle is compliance with medical coding regulations. Optimal coding compliance results in ... and collection of patient service revenue." It is a cycle that describes and explains the life cycle of a patient (and ... A revenue cycle management team is able to handle this, rather than having the doctor take care of patients and learn new ... Revenue Cycle Management teams are responsible for maintaining compliance with coding regulations, such as the ICD-10 code ...
... a program designed to increase patient compliance with and understanding of doctors' orders, resulting in better health ... Patient-Centered Medical Home (PCMH) Tutor Application The Urban Family Practice Application The GBUAHN Application Vazquez ...
The board was also tasked with setting up a compliance program to fix a Medicare billing irregularity that had resulted in a ... the board oversaw an upgrade to the medical center's electronic medical records and system for tracking patient outcomes. ... The election resulted in Republicans winning control of the Presidency and Congress, having campaigned to repeal the law. ...
... overly rapid dose reduction greatly increases the risk of patient non-compliance such as the abuse of illicitly obtained ... Discontinuation of carisoprodol, as with all GABA-ergics, can result in cognitive changes which persist for weeks, months, or ... In some patients, however, and/or early in therapy, carisoprodol can have the full spectrum of sedative side effects and can ... Drug information for Patients, Drug information for Professionals. *. "SOMA 250 mg (carisoprodol) for Painful Musculoskeletal ...
Diabetes mellitus a guide to patient care. Philadelphia: Lippincott Williams & Wilkins. 2007. p. 15. ISBN 978-1-58255-732-8. . ... Type 2 diabetes primarily occurs as a result of obesity and lack of exercise.[1] Some people are more genetically at risk than ... "Influencing self-management: from compliance to collaboration". In Feinglos MN, Bethel MA (eds.). Type 2 diabetes mellitus: an ... Diabetes mellitus a guide to patient care. Philadelphia: Lippincott Williams & Wilkins. 2007. p. 201. ISBN 978-1-58255-732-8. . ...
... but HH compliance before patient contact was 10%-15% lower than after patient contact. Among sites new to the 5 Moments audit ... Results: In late 2010, the overall national HH compliance rate in 521 hospitals was 68.3% (168 641/246 931 moments), ... Phil Russo was an invited speaker and presented an Update in the NHHI. Paul Simpson presented the results of a gender survey ... tool, HH compliance improved from 43.6% (6431/14740) at baseline to 67.8% (106 851/157 708) (P < 0.001). HH compliance was ...
It acts by increasing the required genital blood flow and vaginal compliance resulting in intensified pleasure during sexual ... Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the ... It acts by increasing the required genital blood flow and vaginal compliance resulting in intensified pleasure during sexual ... We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on ...
... regarding the effecs of the economic crisis to health care providers in which patient compliance is a major issue. ... Praise on the practice of Carleton Stickney who dedicated himself to the care of indigent patients; Satisfaction from the ... Reports that the profession of medicine has steadfastly held that physicians responsibility to their patients takes precedence ...
This information was recorded on a Patient-Reported Behaviour (PRB) questionnaire.,/p, ,p,RESULTS: Technique, compliance and ... A nurse-led intervention study: Promoting compliance with Diskus Inhaler use in asthma patients. ... impact of a nurse-led patient assessment and education programme in promoting compliance with inhaler use in asthma patients.,/ ... Promoting compliance with Diskus Inhaler use in asthma patients. Nursing Open. 2014;1(1):42-52 ...
RESULTS: Our calculations showed that patients were significantly more compliant with prescribed theophylline medication than ... Comparison of patients compliance with prescribed oral and inhaled asthma medications.. Kelloway JS1, Wyatt RA, Adlis SA. ... Comparison of medical record data with pharmacy claims data is an effective indirect measure of patients compliance with ... Patients were randomly selected from the pharmacy claims data files of a health maintenance organization. The patients medical ...
RESULTS: Totally 224 patients were diagnosed to have ALL, of them 38 patients went home without receiving any therapy, i.e., ... The patients who had not received any therapy after ALL diagnosis were accounted as early protocol compliance failure, those ... Failure in protocol compliance and treatment was analyzed within different risk groups, patients resident area, and time ... Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia].. [Article in Chinese] ...
Results. Patients. Overall, 263 patients were randomised in 18 centres (median 12 patients, 3 to 24 per centre) from October ... Compliance and efficicay. Overall compliance was satisfactory-on average patients took a mean 100% (4%) of their pills (range ... Patients tolerate hypericum extracts much better than they do tricyclics and therefore by improving patients compliance ... Patients tolerate hypericum extracts much better than they do tricyclics and therefore by improving patients compliance ...
Compliance with ethical standards. The study was approved by the ethics committee of Hacettepe University (HEK12/112-13). ... Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. ... We screened adolescent patients to determine the frequency of ADCK4 mutation and the efficacy of early CoQ10 administration. ... Results. Twenty-eight individuals with bi-allelic mutation from 11 families were identified. Median age at diagnosis was 12.4 ( ...
Results. Baseline Analysis of Different Improvements of HOMA-β. Out of the 784 enrolled patients, 304 patients on acarbose ... Compliance with Ethics Guidelines. All procedures performed in the study were in accordance with the ethical standards of the ... Results. In the highly improved HOMA-β group, patients had higher systolic blood pressure (SBP), 2-h postprandial blood glucose ... As patient-centered management is recommended in T2DM, it is advisable to analyze the baseline characteristics of patients and ...
... and drug compliance scores with achievement of both parameters. Results. Mean (SD) age and duration of diabetes of 207 patients ... This highlights that advices from the dietitian alone would not result in improving dietary compliance and it is necessary to ... Influence of dietary and drug compliance of patients with diabetes on attainment of optimal metabolic (glucose and lipid) ... Association of Self-Reported Dietary and Drug Compliance with Optimal Metabolic Control in Patients with Type 2 Diabetes: ...
i ,Results,/i,. The predominant adverse event was transient abdominal discomfort in 5 of 11 patients, but in 2, both suffering ... patients in a short-term study. This study describes safety, compliance, and changes in quality of life in 11 SBS patients at ... Stoma nipple enlargement was seen in all 9 jejunostomy patients. Reported GLP-2 compliance was excellent (,93%). GLP-2 improved ... i ,Conclusions,/i,. Long-term treatment with GLP-2 is feasible in SBS patients, although caution must be exercised in patients ...
Patients worry that this disapproval can lead to physician hostility, irritation, and lower quality of care resulting in ... Patient Compliance. Patient compliance involves the extent to which the behavior of a patient matches the physicians ... Compliance. The term compliance is the most common way to describe a patient following his/her physicians treatment ... Therefore, we hypothesized that patient-physician concordance will have a positive impact on patient compliance. ...
... as was the link between patient satisfaction and patient compliance. These results invalidate hypotheses 3 and 6, respectively ... Patient commitment toward the physician would positively relate to patient compliance with the proposed treatment.. H6: Patient ... between patient empowerment and patient compliance would be mediated by patient satisfaction with the physician and patient ... of patient empowerment as well as the enhanced patient commitment triggered by patient empowerment that patient compliance ...
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to ... compliance issues. Download Prime PubMed App to iPhone, iPad, or Android ... RESULTS. Of the 73 subjects screened, 61 (40 BoNTA; 21 placebo) with migraine headache diagnosis 1.1 and 1.2 who met all study ... EvaluationDouble-Blind MethodFemaleHumansMaleMiddle AgedMigraine DisordersNeuromuscular AgentsPatient CompliancePatient ...
RESULTS. Patient characteristics and compliance. There were 3,654 patients with diabetes at baseline. Their mean age was 65.4 ... Results were available for 308 (85.3%) patients. In the vitamin E arm, 146 (7.9%) study participants developed overt ... Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes. Results of the HOPE ... Compliance with study drug was high and similar in patients randomized to active vitamin E and to placebo. In the vitamin E ...
Our results suggest how tailoring the treatment strategy according to the complex and specific patient needs make it possible ... This study aimed to assess persistence, compliance, costs and Health-Related Quality-of-Life (HRQoL) in young patients ... While no significantly different overall direct costs trends were found between naïve and non naïve patients, naïve patients ... and non naïve patients. At enrolment, 84% of patients were taking atypical drugs, 3.7% typical, 10% a combination of the two ...
Patient compliance with dapsone administration in leprosy : analytical and pharmaceutical aspects / door Henricus Cornelis ... Compliance in health care / edited by R. Bryan Haynes, D. Wayne Taylor, and David L. Sackett.. by Haynes, R. Brian , Taylor, D ... The role of patient education in the treatment of onchocerciasis in a rural Nigerian community / by Oladimeji Oladepo.. by ... Consent and the incompetent patient : ethics, law, and medicine / edited by Steven R. Hirsch, John Harris.. by Hirsch, Steven R ...
HONcode Trustworthy Health Info Compliance This site complies with the HONcode standard for trustworthy health information: ... Noting the positive results in this patient, and the fact that celiac disease often manifests with only neurological symptoms, ... Their results show that among patients at celiac disease referral centers, psychosocial factors have a greater impact on health ... They found that 1,510 patients, or 67%, had one or more positive antibody-test results; 1,120, or 50% had anti-tissue ...
Results. Compliance, Demographics, and Baseline Characteristics. The number of patients enrolled at each center is listed in ... Patients fasted ≥8 hours before all visits, and all patients received concomitant aspirin (75 to 100 mg/d). Eligible patients ... The goal was 50 patients per treatment group. After 12 placebo patients had been randomized, the remaining patients were ... Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll ...
... Research project for validation of a questionnaire on compliance to treatment in patients with hemophilia. ... Results (where available). View Results. Links. *Source: ... compliance to treatment in patients with hemophilia. It is intended to validate the American VERITAS-PRO scale according to the ... patient compliance to drug therapy, using as gold standard the difference between the treatment prescribed and administered. ...
RESULTS. A total of 1362 patients were enrolled in the study: 1019 (75%) had knee and 343 (25%) hip OA; 913 (67%) were female; ... Compliance with research ethics standards. This study was conducted in compliance, with the protocol, good clinical practices, ... Reporting results of a trial using the MCII (that is, as a percentage of improved patients) provides readers with values which ... But obviously, this choice was arbitrary and affects the results (data not shown). The group of patients in whom MCII is ...
Reducing systematic non-compliance will obviously increase the number of individuals treated, but it may also alter the ... Systematic non-compliance has a greater impact on the potential for elimination of Schistosoma mansoni transmission by ... We study the effect of several alternative treatment and compliance patterns on the dynamics of transmission. We find that the ... Few epidemiological studies have examined longitudinal trends in compliance in the many communities in areas of endemic ...
By doing so, this study aims to contribute to the knowledge on how to increase compliance with obligatory rules and regulations ... Rather, the catalytic actions contribute to (intended) compliance of ward leaders that are motivated, whereas they do not for ... Although all auditors use catalytic enforcement actions, these do not lead to (intended) compliance of all ward leaders. ... For the motivated ward leaders, catalytic enforcement actions contribute to (intended) compliance by increasing ward leaders ...
To study compliance to antituberculosis drug regimens, 172 patients diagnosed with tuberculosis during the first three months ... More information about the disease and the importance of compliance should be provided to tuberculosis patients at the time of ... The patients were interviewed at their homes during July and August 1995. More than one-third (34.9%) of the patients were not ... Les patients ont été interviewés à leur domicile au cours des mois de juillet et août 1995. Plus dun tiers dentre eux (34 ...
Introduction Few patients with type 2 diabetes mellitus (T2DM) achieve recommended glycemic control targets in the Czech ... results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes. ... Compliance with Ethics Guidelines. This article is based on previously conducted studies and does not contain any studies with ... Over patient lifetimes, the costs of diabetes-related complications were lower in patients treated with IDegLira and partly ...
  • We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment. (
  • METHODS: A sample of asthmatic patients (N = 21) were recruited from the population of patients attending an asthma clinic. (
  • However, methods to measure compliance have many limitations. (
  • Methods and Results- In a multicenter, randomized, double-blind study, 123 patients with stable coronary artery disease who were taking aspirin therapy (75 to 100 mg/d) received ticagrelor (180-mg load, 90-mg BID maintenance dose [n=, clopidogrel (600-mg load, 75-mg/d maintenance dose [n=, or placebo (n=12) for 6 weeks. (
  • Current educational delivery methods/materials were clarified with input from multi-disciplinary team members and past/current patients and families. (
  • Barriers to optimal compliance and educational delivery identified included inconsistent patient education provision and documentation methods, handouts of poor visual quality that weren't helpful for people with visual problems, varying content for discharge instructions, and lack of real time assessment of measure compliance. (
  • Methods and Results- Endothelial function was evaluated before and after 4 weeks of different types of ET and after 1 month of detraining by measuring flow-mediated dilation and von Willebrand factor levels at baseline and after ET. (
  • Objectives: To evaluate which type of full-body PPE and which method of donning or doffing PPE have the least risk of contamination or infection for HCW, and which training methods increase compliance with PPE protocols. (
  • More particularly, the invention relates to methods of monitoring patients who are being prescribed potentially abusable or dangerous medications and have been placed on medication maintenance programs for compliance therewith. (
  • RESEARCH DESIGN AND METHODS - We examined the effect of aspirin (81, 162, and 325 mg/day for 4 weeks each) on platelet aspirin responsiveness in 120 stable outpatients (30 diabetic patients and 90 nondiabetic patients) with coronary artery disease (CAD) using light transmittance aggregometry (LTA), VerifyNow, platelet function analyzer (PFA)-100, and levels of urinary 11-dehydro-thromboxane B 2 (11-dh-TxB 2 ). (
  • In addition, no study has compared the effect of multiple aspirin doses on platelet function in both diabetic and nondiabetic patients using various methods. (
  • RESEARCH DESIGN AND METHODS -A total of 62 patients (25 women and 37 men) were studied in a monocenter, randomized, double-blind placebo-controlled study, comparing metformin (850 mg b.i.d.) with placebo in association with CSII during a 6-month period. (
  • One RCT (n=68) of patients with type 2 diabetes had appropriate methods of randomisation, blinding of the carers, general practitioner and outcome assessors, and groups similar at baseline. (
  • One study (n=165) of patients with hypertension did not describe the methods used, and the treatment group had better blood- pressure than controls at baseline. (
  • Comparable results were found for Hamilton anxiety and clinical global impressions scales and were most pronounced for the Zung self rating depression scale. (
  • However, the clinical features that impact the effectiveness of acarbose therapy in Chinese T2DM patients have not been previously studied. (
  • Although conclusions cannot be made in a noncontrolled trial, the high reported compliance might reflect a high treatment satisfaction, where the clinical benefits of GLP-2 may outweigh the discomforts of injections. (
  • This study aimed to assess persistence, compliance, costs and Health-Related Quality-of-Life (HRQoL) in young patients undergoing antipsychotic treatment according to clinical practice. (
  • The importance of the ADP-P2Y 12 receptor interaction has been demonstrated by the clinical benefits associated with the addition of clopidogrel to aspirin therapy in patients with acute coronary syndromes and patients treated with stents. (
  • Clinical severity and impact of haemophilia on quality of life have been generally considered to be lower for haemophilia B (HB) compared with haemophilia A (HA) patients. (
  • In clinical trials, at the group level, results are usually reported as mean and standard deviation of the change in score, which is not meaningful for most readers. (
  • Using criteria such as MCII in clinical trials would provide meaningful information which would help in interpreting the results by expressing them as a proportion of improved patients. (
  • The present analysis indicated that IDegLira was associated with clinical benefits relative to iGlarLixi over patient lifetimes and was likely to be cost-effective in the treatment of patients with T2DM uncontrolled on basal insulin in the Czech Republic. (
  • Clinical results (percentage increase) were recorded and tested for significance. (
  • Healthcare professionals in traditional clinical practice have not often had the opportunity to validate best practices among a large sample of patients. (
  • Neither prevalence nor levels of single microbial antibodies studied differed between the patients and control subjects, or between subgroups of patients created on the basis of clinical characteristics. (
  • Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease ( PALO ALTO Calif.--(BUSINESS WIRE)--Apr. (
  • PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Affymax, Inc. (Nasdaq:AFFY) today announced results to date from two separate Phase 2 clinical trials of Hematide(TM) in dialysis and non-dialysis chronic kidney disease (CKD) patients. (
  • Anne-Marie Duliege, M.D., vice president, Clinical, Medical and Regulatory Affairs for Affymax added, "As we prepare for Phase 3 clinical trials for Hematide, these data support our goal to evaluate the product in a broad CKD patient population. (
  • The Phase 3 studies will assess the safety and efficacy of Hematide in these patient populations and will generate sufficient clinical data to assist physicians in optimizing anemia management in their patients. (
  • This release contains forward-looking statements, including statements regarding the timing, design and results of the Company's clinical trials and drug development program, the timing and likelihood of the commercialization of Hematide. (
  • All patient and clinical data are fictitious and for demonstration purposes only. (
  • The National Institutes of Health (NIH) has launched a phase 2 clinical trial of Rigel Pharmaceuticals' fostamatinib for the treatment of hospitalized COVID-19 patients. (
  • However, there is limited literature available related to caregiver preference or treatment compliance in real-world clinical settings. (
  • The objective of this study was to evaluate treatment preference and compliance with oral and transdermal medications in daily clinical practice in an ethnically diverse patient population from Asia and the Middle East with mild-to-moderate Alzheimer's disease. (
  • The scientists call out widespread use and promotion of laser therapy in clinical practice today and describe a concurrent "relative lack of evidence" supporting claimed clinical results. (
  • They made the assertion after examining the findings related to a randomized clinical trial they conducted of 22 patients receiving regular periodontal maintenance therapy (PMT) at the University of Nebraska in Lincoln. (
  • They collected clinical data at six sites per tooth with identified disease and one healthy site from each patient before therapy and again three months after therapy. (
  • BRUSSELS, Belgium and MENLO PARK, Calif., Oct. 03, 2016 (GLOBE NEWSWIRE) -- UCB (Euronext:UCB) and Dermira, Inc. (NASDAQ:DERM) today announced topline results from CIMPASI-2, a Phase 3, multi-center, placebo-controlled clinical trial evaluating the efficacy and safety of CIMZIA® (certolizumab pegol) in adult patients with moderate-to-severe chronic plaque psoriasis. (
  • The CIMPASI-2 trial results are from the first of three Phase 3 clinical trials to be reported evaluating CIMZIA in this patient population. (
  • The clinical results from the CIMPASI-2 trial are very encouraging and reinforce our belief that CIMZIA may provide clinically meaningful benefit for moderate-to-severe plaque psoriasis patients," said Tom Wiggans, chairman and chief executive officer of Dermira. (
  • The Phase 3 clinical development program, which is led by Dermira in collaboration with UCB Pharma S.A., is designed to evaluate the efficacy and safety of CIMZIA in the treatment of adult patients with moderate-to-severe chronic plaque psoriasis. (
  • If results from the Phase 3 clinical trial program are positive, regulatory submissions in the United States (U.S.), Canada and European Union (EU) are expected. (
  • Provide the clinical confidence your patients deserve. (
  • Quarterly medical records audit continue to monitor healthcare professional record keeping and results are discussed at Clinical Governance meetings as part of our Hospital Audit tracker. (
  • Proactive notification of therapeutic opportunities can improve patient assignment to genomically-driven clinical trials. (
  • However, it may be seen in normotensive patients (with normal blood pressure) before the appearance of clinical hypertension. (
  • In clinical practice it is separated into two different measurements, static compliance and dynamic compliance. (
  • Most radiology departments do not have formal procedures to prevent patients from undergoing unwanted or inappropriate resuscitative interventions, and DNR orders are frequently overruled. (
  • Clinicians who are treating dysphagia in head and neck cancer patients lack evidence-based guidelines so it is challenging to determine which interventions are suitable, but many speech and language therapists encourage patients to undertake exercises intensively throughout head and neck cancer treatment, based on a 'use it or lose it' principle. (
  • A systematic review was chosen as a design to identify primary studies that answeredthe following research question: What is the current evidence on interventions to promote psychiatric patients' compliance to mental health treatment? (
  • This article systematically explains the background and rationale to use of a systematic review, the research objectives, research design and method, steps of the systematic review and conclusion statements regarding interventions to promote psychiatric patients' compliance to mental health treatment. (
  • Studies that investigated the effectiveness of compliance devices in combination with additional interventions were excluded. (
  • Compliance decreases in the following cases: Supine position Laparoscopic surgical interventions Severe restrictive pathologies Chronic restrictive pathologies Hydrothorax Pneumothorax High standing of a diaphragm Acute asthma attacks [Increased compliance also occurs, for an unclear reason] Lung compliance at the US National Library of Medicine Medical Subject Headings (MeSH) Compliance Nikischin W, Gerhardt T, Everett R, Bancalari E (1998). (
  • Aspirin resistance was higher at the 81-mg dose in diabetic versus nondiabetic patients using collagen-induced LTA (27 vs. 4%, P = 0.001), VerifyNow (13 vs. 3%, P = 0.05), and urinary 11-dh-TxB 2 (37 vs. 17%, P = 0.03). (
  • Significant reductions of total cholesterol ( P = 0.04) and LDL cholesterol ( P = 0.05) were observed in patients treated with metformin. (
  • The current sub-analysis of the MARCH trail aims to evaluate the baseline characteristics that may influence the improvement of pancreatic β-cell function and insulin resistance after acarbose therapy in Chinese patients with newly diagnosed T2DM. (
  • Newly diagnosed T2DM Chinese patients with lower baseline HDL-c and higher HbA1c and SBP values are more likely to achieve improvement in beta cell function whereas baseline fasting blood glucose and waist circumference were the significant factors associated with improvement in insulin resistance with acarbose therapy. (
  • All patients had baseline and six-month follow-up visits that included a physical exam with blood pressure screening, electrocoardiogram and blood work. (
  • To compare the effectiveness of using SRP and laser (SRP + L) and SRP alone after treatment of inflamed periodontal pockets in PMT patients, scientists analyzed changes within and between each of two therapy groups - SRP + L and SRP - between baseline (before therapy) and three months after therapy in 22 patients. (
  • Systematic non-compliance to chemotherapeutic treatment among a portion of the eligible population is thought to be a major obstacle to the elimination of helminth infections by mass drug administration (MDA). (
  • Reducing systematic non-compliance will obviously increase the number of individuals treated, but it may also alter the dynamics of parasite transmission. (
  • We find that the impact of different compliance patterns, ranging from random treatment at each round of chemotherapy to systematic non-compliance by a proportion of the population, is very dependent on both transmission intensity in a defined setting and the type of infection that the treatment is targeted at. (
  • Systematic non-compliance has a greater impact on the potential for elimination of Schistosoma mansoni transmission by intensive MDA, than it does on Ascaris lumbricoides . (
  • Blake P, Swart AM, Orton J et al (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. (
  • To determine the minimal clinically important improvement (MCII) of pain, patient's global assessment of disease activity, and functional impairment in patients with knee and hip osteoarthritis (OA). (
  • Concurrent coding-coding a patient's record while the patient is still in house-is an effort many. (
  • According to previous studies, the factors influence the compliance include: (1) socioeconomic status (2) patient's knowledge of their disease and health behavior (3) patient's knowledge of their therapy and medication (4) social and family support (5) patient-doctor relationship and (6) self-perceived convenience. (
  • The recent update statement from the American Heart Association 10 focused on the beneficial impact of resistance training in patients with cardiovascular disease, including those with coronary artery disease. (
  • In addition to gathering information about patient care and preferences, use surveys to assess your strategies for patient education, scheduling regular checkups, tracking and monitoring patient health , getting referrals, and growing your practice. (
  • The influence of these searches on the doctor-patient relationship in the ED has not been investigated, but their effect has been studied in other contexts, especially general practice. (
  • General practice was thought to be the best setting for managing all patients with type 2 diabetes but there were concerns about a lack of resources and unfamiliarity with starting insulin. (
  • Logistic multilevel regression analyses were conducted to determine associations between patient and general practice characteristics and referral compliance. (
  • Conclusion- In patients with recent acute myocardial infarction, ET was associated with improved endothelial function independently of the type of training, but this effect disappeared after 1 month of detraining. (
  • Improvement strategies implemented included stroke program CNS or RN seeing all known stroke/TIA inpatients, creation of a spiral bound stroke educational booklet and an audio CD version, development of a stroke education teaching screen in the electronic health record, and revision of an individualizable Stoke/TIA Patient Discharge Instruction template that included required content. (
  • Strategies to improve compliance should include knowledge of glaucoma. (
  • The patients who had not received any therapy after ALL diagnosis were accounted as early protocol compliance failure, those who received therapy for less than 15 days were regarded as interim failure in protocol compliance, and those who gave up therapy or were lost in follow-up after 15 days with stable disease or complete remission (CR) were accounted as late compliance failure. (
  • More information about the disease and the importance of compliance should be provided to tuberculosis patients at the time of diagnosis and initiation of therapy. (
  • Patients with a diagnosis code had higher mortality (6.3% vs 2.3%), more frequent ICU admissions (44.7% vs 22.5%), and longer hospitalizations (9.2 ± 6.9 days vs 6.9 ± 6.7 days) than did patients with severe sepsis with no diagnosis code (all P (
  • Most patients would never or rarely doubt their diagnosis (79%) or change their treatment plan (91%) because of conflicting online information. (
  • Searching had a positive impact on the doctor-patient interaction in most cases, and was unlikely to cause patients to question the diagnosis or advice of their treating doctor. (
  • To help confirm a diagnosis of asthma, take spirometry measurements (Reduced FEV 1 and FEV 1 /FVC) before and after the patient inhales a short-acting bronchodilator (200-400 µg salbutamol or albuterol). (
  • Referral non-compliance could delay diagnosis and treatment. (
  • Multiple studies have identified single variables or composite scores that help risk stratify patients at the time of acute lung injury (ALI) diagnosis. (
  • However, audits and surveys conducted in different settings reveal that recommended blood glucose and lipid targets have not been achieved by a substantial proportion of patients with diabetes under treatment [ 6 , 7 ]. (
  • To date, no such data are available from Asia and the Middle East, which account for a sizeable proportion of patients with Alzheimer's disease. (
  • In a six-month trial, 241 patients with systolic blood pressure of 140 mmHg or higher, but no evidence of heart disease, were randomized to receive either usual care or telemedicine coupled with home blood pressure monitoring. (
  • An increase in the age and also in the systolic blood pressure (SBP) is accompanied with decrease on arterial compliance. (
  • To measure specific drug compliance and dosing frequency of two asthma medications, we used medical records data and pharmacy claims data from 276 patients who had concurrent prescriptions for inhaled anti-inflammatory agents and oral theophylline. (
  • Influence of dietary and drug compliance of patients with diabetes on attainment of optimal metabolic (glucose and lipid) control remains underexplored in developing countries. (
  • Self-reported dietary and drug compliance score of 0-10, glycosylated hemoglobin (HbA1c), and low-density lipoprotein (LDL) levels were obtained from patients with diabetes. (
  • Factors increasing drug compliance included: disease symptoms, knowledge about the disease, family history of tuberculosis and hospitalization. (
  • Perennial application of SCIT seems to increase compliance in comparison to the preseasonal application. (
  • A total of 146 index patients aged 10-18 years, with newly diagnosed non-nephrotic proteinuria, nephrotic syndrome, or chronic renal failure and end-stage kidney disease (ESKD) of unknown etiology were screened for ADCK4 mutation. (
  • Median age of these 8 patients was 21.5 (range 4.4-39) years. (
  • In this respect, compliance and safety issues were addressed in eleven patients, who were offered GLP-2 for subcutaneous injection TID for two consecutive years intermitted by an 8-week washout period. (
  • Over the past 50 years, patient noncompliance has appeared as a major public health concern and focus of a great deal of research because it endangers patient recovery and imposes a considerable financial burden on health care systems. (
  • Patients were randomly allocated to daily treatment with 400 IU vitamin E and with 10 mg ramipril or their respective placebos and were followed for an average of 4.5 years. (
  • Research on compliance has developed over the past few years, but a lot of work still needs to be done. (
  • Our analysis showed that using this approach, hospitalizations for the average patient fell to less than one every couple of years rather than four to six annually," said lead author Jeremie Estepp, M.D., an assistant member of the St. Jude Department of Hematology. (
  • To identify patients' compliance, "completed treatment years" were determined. (
  • Prescriptions for at least 3 years were received from 42% of patients with pollen SCIT and from 45% of patients with mite SCIT. (
  • Compliance with SLIT was lowest with only 16% of patients receiving prescriptions for at least 3 treatment years. (
  • For more than 85 years, we've been focused on saving and sustaining lives and elevating patient care. (
  • For more than 15 years, The Patient Safety Company (TPSC) has delivered software solutions that do just that. (
  • Five years ago, the company set a goal to expand its offerings to more customers in more countries to the benefit of more patients around the world. (
  • From his early years as the Executive Director of South Eastern Arizona Governments Organization and throughout his 25 years at the Arizona Medical Association, where he was an advocate for physicians and patients, David saw the importance of how public policy could impact, and make better, the life of the individual. (
  • Patients from deprived urban areas and patients aged 18-44 years were less likely to comply, whereas patients aged 65 years and older were more likely to comply. (
  • All enrolled patients were 18 years or older and there were no exclusion criteria for enrollment. (
  • The predominant adverse event was transient abdominal discomfort in 5 of 11 patients, but in 2, both suffering from Crohns disease, it progressed to abdominal pain and led to discontinuation of GLP-2 treatment. (
  • BoNTA may offer benefit in improving compliance because of its long duration of action, injectable route of administration, and its tolerability (adverse event [AE]) profile. (
  • Minimize the need for follow-up visits with a full spectrum of results: HbA1c (NGSP certified and IFCC certified/CLIA waived), Estimated Average Glucose*, Albumin, Creatinine, and Albumin-to-Creatinine Ratio results. (
  • Patients were randomly selected from the pharmacy claims data files of a health maintenance organization. (
  • Data from the remaining 119 medical records were compared with data from pharmacy claims to calculate compliance rates for each medication. (
  • Comparison of medical record data with pharmacy claims data is an effective indirect measure of patients' compliance with prescribed oral theophylline and inhaled anti-inflammatory agents. (
  • The Austrian Haemophilia Registry collects epidemiological data on patients with haemophilia, on treatment modalities and potential side effects. (
  • Compliance data were also collected. (
  • Although neither the prevalence nor the levels of single microbial antibodies studied differed between the patients and the controls, current data suggest that the presence of single or multiple antibodies in patients with many recurrences of AAU compared with patients with none or few recurrences may be a sign of repeated infections, antigen persistence, or raised innate immune responsiveness. (
  • Prescription data of 85,241 patients receiving pollen or mite SCIT and 706 patients receiving pollen SLIT were included in this analysis. (
  • These data show that Hematide results in appropriate managementof he. (
  • These data show that Hematide results in appropriate management of hemoglobin levels in a broad spectrum of patients with CKD from early-stage patients not on dialysis to patients with end-stage renal disease requiring continuous dialysis support," said Dr. Macdougall. (
  • At the time of the presentation, the data generated to date were from two multi-center, open-label studies that have enrolled a total of 304 patients. (
  • For patients who like using their smartphones or tablets to stay connected, the MyCareLink Heart™ mobile app can be used to automatically send device data, replacing the bedside monitor. (
  • Patients with Medtronic heart devices with Bluetooth ® wireless telemetry can use their smartphone to automatically transfer device data via the MyCareLink Heart app. (
  • The app is free, and information can be sent on a scheduled basis or any time a doctor requests heart device data from a patient. (
  • Patients may need to update or replace their mobile devices or OS to use the app to transfer data between their heart devices and the Medtronic CareLink network. (
  • There are very few data for coronary patients, 10,18 and the available information generally focuses on the effect of associated resistance and aerobic training. (
  • With customers across Europe, Canada, Australia, Asia, South America and the US, the company required a cloud provider with a global footprint to manage compliance with country-specific data sovereignty laws that protect sensitive personal data. (
  • Using big data analytics to understand results and generate systems to scale is essential to keeping up with the data being accumulated to deliver precision medicine. (
  • Referral compliance was based on claims data of medical specialist care. (
  • Select data on 149 consecutive patients were collected prospectively, and additional data were then extracted from the medical record retrospectively. (
  • Alere products give providers, physicians and patients access to the right information at the right time. (
  • The Precision Medicine conference will assess current developments and steps needed to make personalized therapy available to the physicians and patients. (
  • In a gatekeeper system, primary care physicians and patients jointly decide whether or not medical specialist care is needed. (